Warning letter
Moehs Cantabra, S.L. [ARCHIVED]: warning letter of Apr 14, 2011
FDA warning letter 165192 · Center for Drug Evaluation and Research
Key facts
| Reference number | 165192 |
|---|---|
| Company | Moehs Cantabra, S.L. [ARCHIVED] |
| Subject | CGMP/Adulterated |
| Issue date | Apr 14, 2011 |
| Posted date | Apr 14, 2011 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | Polanco |
| Inspection start date | Dec 13, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: